356 related articles for article (PubMed ID: 7467658)
1. [Effects of sulfinpyrazone on early ventricular fibrillation and 2d-phase arrhythmias in acute myocardial infarction (author's transl)].
Gülker H; Bender F; Thale J; Heuer H; Kristek J; Dorsel T; Pierchalla P
Z Kardiol; 1980 Nov; 69(11):751-6. PubMed ID: 7467658
[TBL] [Abstract][Full Text] [Related]
2. [Antiarrhythmic therapy with flecainide in acute experimental myocardial infarction (author's transl)].
Gülker H; Bender F; Brisse B; Thale J; Heuer H; Kristek J; Schindelhauer F; Teerling K
Z Kardiol; 1981 Feb; 70(2):124-30. PubMed ID: 7222906
[TBL] [Abstract][Full Text] [Related]
3. [Sulfinpyrazone in the prevention of sudden death after myocardial infarction (author's transl)].
Sherry S
MMW Munch Med Wochenschr; 1980 Apr; 122(14):517-24. PubMed ID: 6769032
[TBL] [Abstract][Full Text] [Related]
4. The anturane reinfarction trial.
Sherry S
Circulation; 1980 Dec; 62(6 Pt 2):V73-8. PubMed ID: 7438382
[TBL] [Abstract][Full Text] [Related]
5. [Prognostic significance of arrhythmias in acute myocardial infarction (author's transl)].
Breithardt G; Seipel L; Loogen F
Z Kardiol; 1977 Jun; 66(6):267-72. PubMed ID: 331707
[TBL] [Abstract][Full Text] [Related]
6. [Preventive antifibrillatory treatment of sudden cardiac death in acute myocardial infarct].
Thale J; Gülker H; Hindricks G; Haverkamp W; Pollock B; Buchwalsky R
Z Kardiol; 1988; 77 Suppl 4():11-22. PubMed ID: 3062962
[TBL] [Abstract][Full Text] [Related]
7. [Comparative studies on the anti-arrhythmic and anti-fibrillatory effectiveness of verapamil and nifedipine following acute coronary artery occlusion and reperfusion].
Gülker H; Thale J; Brisse B; Bender F
Z Kardiol; 1984 Aug; 73(8):515-24. PubMed ID: 6495811
[TBL] [Abstract][Full Text] [Related]
8. Lidocaine prophylaxis for fatal ventricular arrhythmias after acute myocardial infarction.
Pharand C; Kluger J; O'Rangers E; Ujhelyi M; Fisher J; Chow M
Clin Pharmacol Ther; 1995 Apr; 57(4):471-8. PubMed ID: 7712677
[TBL] [Abstract][Full Text] [Related]
9. Effects of diltiazem upon experimental ventricular dysrhythmias.
Patterson E; Eller BT; Lucchesi BR
J Pharmacol Exp Ther; 1983 Apr; 225(1):224-33. PubMed ID: 6834274
[TBL] [Abstract][Full Text] [Related]
10. Sudden cardiac death: identifying and managing the patient at risk.
Sridharan MR; Checton J
Geriatrics; 1985 Jan; 40(1):63-9. PubMed ID: 3965356
[TBL] [Abstract][Full Text] [Related]
11. Sulfinpyrazone in the prevention of cardiac death after myocardial infarction. The Anturane Reinfarction Trial.
Anturane Reinfarction Trial Research Group
N Engl J Med; 1978 Feb; 298(6):289-95. PubMed ID: 340942
[TBL] [Abstract][Full Text] [Related]
12. Experimental and clinical effects of bretylium tosylate on ventricular fibrillation, arrhythmias, and heart block.
Bacaner M
Geriatrics; 1971 Jan; 26(1):132-48. PubMed ID: 5539447
[No Abstract] [Full Text] [Related]
13. Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry).
Piccini JP; Hranitzky PM; Kilaru R; Rouleau JL; White HD; Aylward PE; Van de Werf F; Solomon SD; Califf RM; Velazquez EJ
Am J Cardiol; 2008 Dec; 102(11):1427-32. PubMed ID: 19026290
[TBL] [Abstract][Full Text] [Related]
14. [Lidocaine therapy in the early phase of arrhythmia after acute myocardial infarct without influence on the fibrillatory threshold and on the spontaneous ventricular fibrillation of the heart].
Krämer B; Gülker H; Stephan K; Meesmann W
Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1096-9. PubMed ID: 1029932
[No Abstract] [Full Text] [Related]
15. Familial sudden death is an important risk factor for primary ventricular fibrillation: a case-control study in acute myocardial infarction patients.
Dekker LR; Bezzina CR; Henriques JP; Tanck MW; Koch KT; Alings MW; Arnold AE; de Boer MJ; Gorgels AP; Michels HR; Verkerk A; Verheugt FW; Zijlstra F; Wilde AA
Circulation; 2006 Sep; 114(11):1140-5. PubMed ID: 16940195
[TBL] [Abstract][Full Text] [Related]
16. [Initial serum potassium level in relation to cardiac arrhythmias in acute myocardial infarction (author's transl)].
Beck OA; Hochrein H
Z Kardiol; 1977 Apr; 66(4):187-90. PubMed ID: 857457
[TBL] [Abstract][Full Text] [Related]
17. Antiarrhythmic effects of stirocainide in acute myocardial infarction.
Gülker H; Bender F; Thale J; Heuer H; Kristek J; Hübner G; Dorsel T; Schmidt J
Arzneimittelforschung; 1984; 34(5):559-62. PubMed ID: 6540572
[TBL] [Abstract][Full Text] [Related]
18. Cardiac death prevention in post-myocardial infarction patients: a review.
Boissel JP; Leizorovicz A; Faucomprez C
Acta Cardiol Suppl; 1980; (25):147-79. PubMed ID: 6103625
[No Abstract] [Full Text] [Related]
19. [Sulfinpyrazone (Anturane)--new indication: myocardial infarct?].
Bolte HD
MMW Munch Med Wochenschr; 1980 Apr; 122(14):507-8. PubMed ID: 6769029
[No Abstract] [Full Text] [Related]
20. [Pharmacological possibilities for the prevention of complications following myocardial infarction].
Szekeres L
J Pharmacol; 1986; 17 Suppl 2():65-81. PubMed ID: 3821131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
